Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 5
2006 6
2007 8
2008 7
2009 4
2010 6
2011 7
2012 3
2013 5
2014 5
2015 5
2016 5
2017 4
2018 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28104761

62 results

Results by year

Filters applied: . Clear all
Page 1
Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
Sanz-Ruiz R, Casado Plasencia A, Borlado LR, Fernández-Santos ME, Al-Daccak R, Claus P, Palacios I, Sádaba R, Charron D, Bogaert J, Mulet M, Yotti R, Gilaberte I, Bernad A, Bermejo J, Janssens S, Fernández-Avilés F. Sanz-Ruiz R, et al. Circ Res. 2017 Jun 23;121(1):71-80. doi: 10.1161/CIRCRESAHA.117.310651. Epub 2017 May 22. Circ Res. 2017. PMID: 28533209 Clinical Trial.
Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction.
Taljaard M, Ward MR, Kutryk MJ, Courtman DW, Camack NJ, Goodman SG, Parker TG, Dick AJ, Galipeau J, Stewart DJ. Taljaard M, et al. Am Heart J. 2010 Mar;159(3):354-60. doi: 10.1016/j.ahj.2009.12.021. Am Heart J. 2010. PMID: 20211295 Clinical Trial.
[Stem cells after myocardial infarction].
Schächinger V, Dimmeler S, Zeiher AM. Schächinger V, et al. Herz. 2006 Apr;31(2):127-36; quiz 142-3. doi: 10.1007/s00059-006-2794-x. Herz. 2006. PMID: 16738836 Review. German.
Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.
Döbert N, Britten M, Assmus B, Berner U, Menzel C, Lehmann R, Hamscho N, Schächinger V, Dimmeler S, Zeiher AM, Grünwald F. Döbert N, et al. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1146-51. doi: 10.1007/s00259-004-1490-4. Epub 2004 Apr 3. Eur J Nucl Med Mol Imaging. 2004. PMID: 15064873 Clinical Trial.
Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C. Dill T, et al. Am Heart J. 2009 Mar;157(3):541-7. doi: 10.1016/j.ahj.2008.11.011. Epub 2009 Jan 31. Am Heart J. 2009. PMID: 19249426 Clinical Trial.
62 results